Blueprint is the diagnostic layer HVL runs across portfolio companies: a consistent, comparable read on which companies are genuinely ahead, plus the team and capital to build what comes next.
Founded by Shegun Otulana after a $1.25B exit from Therapy Brands. We run a venture studio and a co-investment fund, not an advisory practice.
Every CEO in your portfolio says yes when you ask about AI. You don’t want to force a one-size playbook on companies that don’t need it, and right now you don’t have a consistent way to tell which ones are genuinely ahead and which are performing AI literacy for the board.
Blueprint is that read.
We run Blueprint across your portfolio, co-branded. Each portfolio company pays for its own engagement, so the partnership itself costs your fund nothing. Your payoff is a comparable AXIS benchmark across every company you own, and a real read on which ones are actually ahead.
Bring Blueprint into a process pre- or post-close. A company that can show a Gap Map and a Builder Roster tells a sharper AI-maturity story to buyers than one with a slide deck. A useful differentiator in a crowded process.
Blueprint gives you the evidence for that belief instead of just the belief. A comparable score across every portco, in writing, before the next board meeting.
The same AXIS framework, run the same way, across every company. Comparable results, not one-off custom work you can’t line up side by side.
Each portco gets its own honest assessment and its own internal champions identified, with their consent.
When a portco surfaces an opportunity bigger than a workflow, we have a fund and a team. We co-invest alongside you, not sell you an add-on engagement.
Strategy firms sell advice and leave. We run a venture studio and a co-investment fund. The same discipline that finds an edge inside a company we’re building from scratch is what we bring to your portfolio company’s org chart.
Five questions worth asking every portfolio CEO before you take “we’re doing AI” at face value.
We agree which portcos are in scope and whether it runs as a cohort or on a rolling basis.
Each company runs the same two-week assessment. Results are comparable across the portfolio.
You see the benchmark. Each portco decides, with you, whether to move into activation.
Neither do we. Diagnostic first, no pressure. A portco that scores well is useful information too.
It sits underneath it, not on top of it. Blueprint is the execution layer, not another slide in the deck.
This starts with a conversation, one operator to another. No deck, no pressure.